Skip to main content

Table 8 Factors associated with EFS rate

From: The effect of ERCC1 and ERCC2 gene polymorphysims on response to cisplatin based therapy in osteosarcoma patients

Variables P value Hazard ratio 95.0% CI
ERCC1 8092 C allele 0.044 59.008 (Reference =1) 1.122–3102.7
ERCC2 312 G allele 0.562 2.085 (Reference = 1) 0.174–24.955
Histology 0.026 0.149 (Reference = 1) 0.028–0.792
Presence of metastasis 0.078 0.406 (Reference = 1) 0.149–1.106